The connection between kidney health and parathyroid function has become a central focus for global health organizations this year. The Parathyroid Disorders Market growth is increasingly linked to the rising prevalence of chronic kidney disease (CKD) worldwide. As the kidneys lose their ability to process phosphorus and activate vitamin D, the parathyroid glands overcompensate, leading to secondary and sometimes tertiary hyperparathyroidism that requires aggressive intervention.

Innovative diagnostic assays that measure "intact" PTH with greater specificity are now widely available, even in emerging economies. This democratization of high-end diagnostics is closing the gap in care between developed and developing nations. As more patients receive early screenings during routine metabolic panels, the volume of treated cases is rising, creating a robust environment for manufacturers of both diagnostic reagents and therapeutic agents.

FAQ:

• Q: Why does kidney disease affect the parathyroid glands?

• A: Failing kidneys disrupt the balance of calcium and phosphorus, which triggers the parathyroid to overproduce hormones.

Related Reports: